The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Organogenesis Holdings Inc (NASDAQ: ORGO) closed at $3.06 down -42.70% from its previous closing price of $5.34. In other words, the price has decreased by -$42.70 from its previous closing price. On the day, 11.21 million shares were traded.
Ratios:
For a deeper understanding of Organogenesis Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.67 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On February 07, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $5.
On June 15, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $5.Morgan Stanley initiated its Equal-Weight rating on June 15, 2023, with a $5 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’25 when Driscoll Michael Joseph bought 25,000 shares for $5.08 per share.
Driscoll Michael Joseph sold 25,000 shares of ORGO for $127,535 on Mar 04 ’25. The Director now owns 166,879 shares after completing the transaction at $5.10 per share. On Dec 13 ’24, another insider, Gillheeney Gary S., who serves as the President and CEO of the company, sold 55,615 shares for $3.36 each. As a result, the insider received 186,866 and left with 3,044,779 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.85 while its Price-to-Book (P/B) ratio in mrq is 1.60.
Stock Price History:
Over the past 52 weeks, ORGO has reached a high of $6.71, while it has fallen to a 52-week low of $2.21. The 50-Day Moving Average of the stock is -35.52%, while the 200-Day Moving Average is calculated to be -14.34%.
Shares Statistics:
A total of 126.85M shares are outstanding, with a floating share count of 64.40M. Insiders hold about 49.24% of the company’s shares, while institutions hold 47.98% stake in the company.
